No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs140922782 |
chr20:14900833-14900834 |
Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs144794967 |
chr20:14900875-14900876 |
Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs1018659 |
chr20:14900886-14900887 |
Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs575152044 |
chr20:14900896-14900897 |
Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs34708804 |
chr20:14900928-14900929 |
Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs569510240 |
chr20:14900995-14900996 |
Weak transcription Active TSS Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs186184361 |
chr20:14901027-14901028 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs560918644 |
chr20:14901030-14901031 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs147960988 |
chr20:14901043-14901044 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs540316072 |
chr20:14901054-14901055 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs2423845 |
chr20:14901070-14901071 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs371119057 |
chr20:14901116-14901117 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs532084686 |
chr20:14901141-14901142 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs140227926 |
chr20:14901171-14901172 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs367763841 |
chr20:14901172-14901173 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs190793595 |
chr20:14901175-14901176 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs114232597 |
chr20:14901186-14901187 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs548220368 |
chr20:14901206-14901207 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs566849154 |
chr20:14901296-14901297 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs527731917 |
chr20:14901307-14901308 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs11906455 |
chr20:14901322-14901323 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs142973735 |
chr20:14901326-14901327 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs538359003 |
chr20:14901342-14901343 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs555052143 |
chr20:14901371-14901372 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs374084464 |
chr20:14901378-14901379 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs574802038 |
chr20:14901391-14901392 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs568701434 |
chr20:14901512-14901513 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs536132630 |
chr20:14901513-14901514 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs985638 |
chr20:14901521-14901522 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
30 |
rs183705432 |
chr20:14901528-14901529 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs546702959 |
chr20:14901573-14901574 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs539803795 |
chr20:14901623-14901624 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs566597543 |
chr20:14901628-14901629 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs151047494 |
chr20:14901678-14901679 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs553858892 |
chr20:14901725-14901726 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs576499889 |
chr20:14901732-14901733 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs543929828 |
chr20:14901737-14901738 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs372075025 |
chr20:14901771-14901772 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs2423846 |
chr20:14901776-14901777 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
40 |
rs542103090 |
chr20:14901797-14901798 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs560142587 |
chr20:14901839-14901840 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs368386174 |
chr20:14901845-14901846 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs188177390 |
chr20:14901862-14901863 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs552255264 |
chr20:14901864-14901865 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs76715283 |
chr20:14901870-14901871 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs191603413 |
chr20:14901884-14901885 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs550334191 |
chr20:14901890-14901891 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs568664575 |
chr20:14901917-14901918 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs140914882 |
chr20:14901940-14901941 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs554350355 |
chr20:14901959-14901960 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|